선택적 Cyclooxygenase-2 저해제 국소 도포가 토끼 귀의 창상반흔에 미치는 영향

The Effect of a Topical Selective Cyclooxygenase-2 Inhibitor on Skin-Wound Scarring of the Rabbit Ear

  • 김도엽 (고신대학교 의과대학 성형외과학교실) ;
  • 박진형 (고신대학교 의과대학 성형외과학교실) ;
  • 천봉권 (고신대학교 의과대학 병리학교실) ;
  • 한예식 (고신대학교 의과대학 성형외과학교실)
  • Kim, Do-Yup (Department of Plastic and Reconstructive Surgery, Kosin University College of Medicine) ;
  • Park, Jin-Hyung (Department of Plastic and Reconstructive Surgery, Kosin University College of Medicine) ;
  • Chun, Bong-Kwon (Department of Pathology, Kosin University College of Medicine) ;
  • Han, Yea-Sik (Department of Plastic and Reconstructive Surgery, Kosin University College of Medicine)
  • 투고 : 2010.12.06
  • 심사 : 2011.05.23
  • 발행 : 2011.07.10

초록

Purpose: The inflammatory phase is considered an integral part of adult wound healing, but fetal wound healing studies have shown scarless healing results in the absence of the inflammation process. The COX-2 pathway is an essential component of inflammation. The purpose of this study is to identify the effect of a topical selective COX-2 inhibitor on inflammation in rabbit skin wound healing and scarring. Methods: Full-thickness wounds were made on 6 New Zealand rabbits' ears. Topical 5% celecoxib + vehicle (experimental tissue) and vehicle only (controlled tissue) were applied daily for 14d on each side of the ears. Scar samples were harvested at 2 wks, 4 wks, and 8 wks after the wounding. Each sample was stained with hematoxylin and eosin and the Masson's trichrome stain to evaluate inflammation and scar formation. Results: Histological analysis demonstrated a significant reduction of inflammation, neovascularization, and scar elevation in the experimental tissue as compared to the control. Additionally, experimental tissue exhibited faster improvement of collagen organization similar to that of normal tissue. Conclusion: This study suggests that the topical application of a selective COX-2 inhibitor on a rabbit ear wound resulted in decreased inflammation and had a positive effect on the reduction of scar formation.

키워드

참고문헌

  1. Morykwas MJ, Ledbetter MS, Ditesheim JA, White WL, Vander Ark AD, Argenta LC: Cellular inflammation of fetal excisional wounds: effects of amniotic fluid exclusion. Inflammation 15: 173, 1991 https://doi.org/10.1007/BF00918644
  2. Lin RY, Sullivan KM, Argenta PA, Meuli M, Lorenz HP, Adzick NS: Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair. Ann Surg 222: 146, 1995 https://doi.org/10.1097/00000658-199508000-00006
  3. Wilgus TA.: Immune cells in the healing skin wound: influential players at each stage of repair. Pharmacol Res 58: 112, 2008 https://doi.org/10.1016/j.phrs.2008.07.009
  4. Henson PM, Johnston RB Jr: Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J Clin Invest 79: 669, 1987 https://doi.org/10.1172/JCI112869
  5. Martin P, D'Souza D, Martin J, Grose R, Cooper L, Maki R, McKercher SR: Wound healing in the PU. 1 null mousetissue repair is not dependent on inflammatory cells. Current Biology 13: 1122, 2003 https://doi.org/10.1016/S0960-9822(03)00396-8
  6. Dovi JV, He LK, DiPietro LA: Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 73: 448, 2003 https://doi.org/10.1189/jlb.0802406
  7. Beausang E, Floyd H, Dunn KW, Orton CI, Ferguson MW: A new quantitative scale for clinical scar assessment. Plast Reconstr Surg 102: 1954, 1998 https://doi.org/10.1097/00006534-199811000-00022
  8. Wilgus TA, Bergdall VK, Tober KL, Hill KJ, Mitra S, Flavahan NA, Oberyszyn TM: The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing. Am J Pathol 165: 753, 2004 https://doi.org/10.1016/S0002-9440(10)63338-X
  9. Miyajima A, Ito K, Asano T, Seta K, Ueda A, Hayakawa M: Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction? J Urol 166: 1124, 2001 https://doi.org/10.1016/S0022-5347(05)65933-2
  10. Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB: Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem 263: 7741, 1988
  11. Amadeu T, Braune A, Mandarim-de-Lacerda C, Porto LC, Desmouliere A, Costa A: Vascularization pattern in hypertrophic scars and keloids: a stereological analysis. Pathol Res Pract 199: 469, 2003 https://doi.org/10.1078/0344-0338-00447
  12. Szpaderska AM, Walsh CG, Steinberg MJ, DiPietro LA: Distinct patterns of angiogenesis in oral and skin wounds. J Dent Res 84: 309, 2005 https://doi.org/10.1177/154405910508400403
  13. Blomme EAG, Chinn KS, Hardy MM, Casler JJ, Kim SH, Opsahl AC, Hall WA, Trajkovic D, Khan KN, Tripp CS: Selective cyclooxygenase-2 inhibition does not affect the healing of cutaneous full-thickness incisional wounds in SKH-1 mice. Br J Dermatol 148: 211, 2003 https://doi.org/10.1046/j.1365-2133.2003.05065.x
  14. Rossiello L, D'Andrea F, Grella R, Signoriello G, Abbondanza C, De Rosa C, Prudente M, Morlando M, Rossiello R: Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues. Wound Repair Regen 17: 750, 2009 https://doi.org/10.1111/j.1524-475X.2009.00530.x
  15. Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszyn TM: Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Mol Carcinog 38: 49, 2003 https://doi.org/10.1002/mc.10141